Exablate Prime | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,577 results for “Exablate Prime”

Trials

View all 803 →

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

200 participants · First posted May 23, 2022

OpSens PRIME CLASS

32 participants · First posted Oct 7, 2021

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

2,000 participants · First posted May 5, 2011

Drugs

View all 93 →

Grafix

PRIME-2-CoV-Beta

Neo-X-Prime MacroGenics

Organizations

View all 21 →

PRIME MEDICINE

India

Prime Commerce, LLC

United States

Prime Potions Inc

Canada

News

View all 660 →

Insightec's Exablate Prime Receives FDA Approval for Use with Philips MRI Systems

Insightec's Exablate Prime Receives FDA and CE Mark for Philips MRI Integration

FDA Approves Insightec's Exablate Neuro for Advanced Parkinson's Disease Treatment

Page 1 of 158